AI Maverick Intel, Inc. (BINP)

OTCMKTS · Delayed Price · Currency is USD
0.0380
+0.0218 (134.57%)
Jul 16, 2025, 3:03 PM EDT
-81.00%
Market Cap2.05M
Revenue (ttm)92.26K
Net Income (ttm)-1.62M
Shares Out53.99M
EPS (ttm)-46.27
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,000
Average Volume27,077
Open0.0380
Previous Close0.0162
Day's Range0.0380 - 0.0380
52-Week Range0.0162 - 0.4480
Beta-4.37
RSI38.82
Earnings Daten/a

About AI Maverick Intel

AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California... [Read more]

Sector Healthcare
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol BINP
Full Company Profile

Financial Performance

Financial Statements

News

Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval

Company Has Initiated FINRA Process to Complete Rebranding and Ticker Update NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bionoid Pharma, Inc. (OTC PINK:BINP) ("Bionoid" or the "Company") is p...

6 weeks ago - Accesswire

Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation

NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformati...

2 months ago - Accesswire

Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for t...

3 months ago - Accesswire

Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements

NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its i...

3 months ago - Accesswire

Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture...

4 months ago - Accesswire

Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022 an...

4 months ago - Accesswire

Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025

Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company remains committed to its strategic growth plan, whi...

6 months ago - Accesswire

Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.

NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Lett...

6 months ago - Accesswire

Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.

NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd. to...

7 months ago - Accesswire

AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast

NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this...

8 months ago - Accesswire

The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time

NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) - Bionoid Pharma, Inc. ("Bionoid") ("BINP") (OTC Pink:BINP), the new owner of the AI Maverick platfor...

8 months ago - Accesswire

Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion

TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a criti...

8 months ago - Accesswire

Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.

TORONTO, ON / ACCESSWIRE / November 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is excited to announce the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store...

8 months ago - Accesswire

Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is pleased to announce the formal engagement of Olayinka Oyebola & Co., a PCAOB-registered ...

8 months ago - Accesswire

Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap

AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlin...

9 months ago - Accesswire

Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp.

" Paving the Way for a Safer World Through Advanced Emergency Communications " TORONTO, ON / ACCESSWIRE / December 8, 2023 / Bionoid Pharma, Inc. ("BINP" or the "Company") (OTC PINK:BINP) is pleased t...

1 year ago - Accesswire

Bionoid Pharma Signs Exclusive License Agreement with Global Alerts Corp.

Landmark Deal Signed in Global Mass Notification Market: Exclusive License Agreement for Rapid Deployment of World-Leading Early Warning Technology TORONTO, ON / ACCESSWIRE / October 12, 2023 / Bionoi...

1 year ago - Accesswire

Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.

" Paving the Way for a Safer World Through Advanced Emergency Communications " TORONTO, ON / ACCESSWIRE / August 24, 2023 / Bionoid Pharma, Inc. ("BINP" or the "Company") (OTC PINK:BINP) is pleased to...

2 years ago - Accesswire

Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.

TORONTO, ON / ACCESSWIRE / March 22, 2023 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) announced today that it has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts C...

2 years ago - Accesswire